Geng Zhi, Zhao Ting, Li Ke, Liang Li-Ling, Chen Ming-Xuan, Zhou Zhijing, Dai Jun, Dai Zongjie, Jia Kai-Zhi
Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Key Laboratory of Industrial Microbiology, National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Hubei University of Technology, Wuhan 430068, China.
Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China.
J Agric Food Chem. 2024 Nov 13;72(45):25219-25228. doi: 10.1021/acs.jafc.4c08469. Epub 2024 Oct 30.
Compared with mono--glycosylation, di--glycosylation endows the precursor with better performance. However, the mining and engineering of di--glycosylation patterns of glycosyltransferases are limited, hindering their synthetic applications. Here, an xenobiotic-transforming glycosyltransferase, UGT72B1, was found to catalyze the glycosylation of endogenous quercetin and its monoglycosides, generating di-glucosides. Mutating M17/G18/Y315 into L/T/Q in UGT72B1 altered its regioselectivity toward quercetin 7--glucoside, enzymatically generating another 3,7-di--glycoside with up to a 100% conversion rate, and increased the sugar donor preference. Altering the regiospecificity of glycosyltransferases likely required coordination between the entrance and the active site, where the orientations of the sugar acceptors and donors shift to adopt a lower binding energy state. Moreover, quercetin 3,4'-di--β-d-glucoside and quercetin 3,7-di--β-d-glucoside synthesized were found to have the highest anti-inflammatory activities. Overall, this work presents an efficient strategy to engineer glycosylation patterns for the synthesis of quercetin di--β-d-glucosides to be used as food additives, therapeutics, and nutraceuticals.
与单糖基化相比,双糖基化赋予前体更好的性能。然而,糖基转移酶双糖基化模式的挖掘和工程化受到限制,阻碍了它们的合成应用。在此,发现一种外源化合物转化糖基转移酶UGT72B1可催化内源性槲皮素及其单糖苷的糖基化反应,生成双糖苷。将UGT72B1中的M17/G18/Y315突变为L/T/Q,改变了其对槲皮素7-葡萄糖苷的区域选择性,酶促生成另一种转化率高达100%的3,7-双糖苷,并增加了糖供体偏好性。改变糖基转移酶的区域特异性可能需要入口和活性位点之间的协同作用,糖受体和供体的方向会发生转变以采用较低的结合能状态。此外,发现合成的槲皮素3,4'-双-β-d-葡萄糖苷和槲皮素3,7-双-β-d-葡萄糖苷具有最高的抗炎活性。总体而言,这项工作提出了一种有效的策略,用于工程化糖基化模式以合成用作食品添加剂、治疗剂和营养保健品的槲皮素双-β-d-葡萄糖苷。